OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice
Jun Zhu, Pamela M. Quizon, Yingying Wang, et al.
Neuropharmacology (2022) Vol. 220, pp. 109239-109239
Open Access | Times Cited: 15
Jun Zhu, Pamela M. Quizon, Yingying Wang, et al.
Neuropharmacology (2022) Vol. 220, pp. 109239-109239
Open Access | Times Cited: 15
Showing 15 citing articles:
The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases
Sarah E. Davis, Abagail B. Cirincione, Ana Catya Jiménez-Torres, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15340-15340
Open Access | Times Cited: 25
Sarah E. Davis, Abagail B. Cirincione, Ana Catya Jiménez-Torres, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15340-15340
Open Access | Times Cited: 25
Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions
Mark D. Namba, Qiaowei Xie, Jacqueline M. Barker
Brain Behavior and Immunity (2023) Vol. 113, pp. 453-475
Open Access | Times Cited: 13
Mark D. Namba, Qiaowei Xie, Jacqueline M. Barker
Brain Behavior and Immunity (2023) Vol. 113, pp. 453-475
Open Access | Times Cited: 13
Exploring new frontiers in the treatment of HIV–associated neurocognitive disorder
Barkha J. Yadav-Samudrala, Sylvia Fitting
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 2, pp. 100040-100040
Closed Access
Barkha J. Yadav-Samudrala, Sylvia Fitting
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 2, pp. 100040-100040
Closed Access
Hinokinin Decreases Methamphetamine-Induced Hyperlocomotion via the Regulatory Effects on Dopamine Levels
Byung Tae Choi, Sun Mi Gu, Abdulaziz Jabborov, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Byung Tae Choi, Sun Mi Gu, Abdulaziz Jabborov, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation
Lauren A. Buck, Qiaowei Xie, Michelle Willis, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Lauren A. Buck, Qiaowei Xie, Michelle Willis, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Allosteric modulation of serotonin and dopamine transporters: New insights from computations and experiments
Hoang Linh Nguyen, Mary Hongying Cheng, Ji Young Lee, et al.
Current Research in Physiology (2024) Vol. 7, pp. 100125-100125
Open Access | Times Cited: 2
Hoang Linh Nguyen, Mary Hongying Cheng, Ji Young Lee, et al.
Current Research in Physiology (2024) Vol. 7, pp. 100125-100125
Open Access | Times Cited: 2
Identification of pyrimidine structure-based compounds as allosteric ligands of the dopamine transporter as therapeutic agents for NeuroHIV
Ana Catya Jiménez-Torres, Jamison A. Hastie, Sarah E. Davis, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 2, pp. 100021-100021
Closed Access | Times Cited: 1
Ana Catya Jiménez-Torres, Jamison A. Hastie, Sarah E. Davis, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 2, pp. 100021-100021
Closed Access | Times Cited: 1
Impact of HIV-1 Tat protein on methamphetamine-induced inhibition of vesicular monoamine transporter2-mediated dopamine transport and methamphetamine conditioned place preference in HIV-1 Tat transgenic mice.
Jun Zhu, Abagail B. Cirincione, Matthew J. Strauss, et al.
European Journal of Pharmacology (2024), pp. 177030-177030
Closed Access | Times Cited: 1
Jun Zhu, Abagail B. Cirincione, Matthew J. Strauss, et al.
European Journal of Pharmacology (2024), pp. 177030-177030
Closed Access | Times Cited: 1
Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice
Sarah E. Davis, Mark J. Ferris, Subramaniam Ananthan, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 2, pp. 306-314
Open Access | Times Cited: 6
Sarah E. Davis, Mark J. Ferris, Subramaniam Ananthan, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 2, pp. 306-314
Open Access | Times Cited: 6
Molecular mechanisms of dopaminergic transmission in NeuroHIV
Jun Zhu, Sarah E. Davis, Chang‐Guo Zhan, et al.
Elsevier eBooks (2024), pp. 379-398
Closed Access
Jun Zhu, Sarah E. Davis, Chang‐Guo Zhan, et al.
Elsevier eBooks (2024), pp. 379-398
Closed Access
A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation
Alexis F. League, Barkha J. Yadav-Samudrala, Ramya Kolagani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Alexis F. League, Barkha J. Yadav-Samudrala, Ramya Kolagani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Effects of SRI-32743, a Novel Quinazoline Structure-Based Compound, on HIV-1 Tat and Cocaine Interaction with Norepinephrine Transporter
Ana Catya Jiménez-Torres, Katherine D. Porter, Jamison A. Hastie, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7881-7881
Open Access
Ana Catya Jiménez-Torres, Katherine D. Porter, Jamison A. Hastie, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7881-7881
Open Access
Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation
Lauren A. Buck, Qiaowei Xie, Michelle Willis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Lauren A. Buck, Qiaowei Xie, Michelle Willis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation
Jacqueline M. Barker, Lauren Buck, Qiaowei Xie, et al.
Research Square (Research Square) (2023)
Open Access
Jacqueline M. Barker, Lauren Buck, Qiaowei Xie, et al.
Research Square (Research Square) (2023)
Open Access
SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice
Haylee R. Hammond, Shainnel O. Eans, Thomas J. Cirino, et al.
NeuroImmune Pharmacology and Therapeutics (2023) Vol. 3, Iss. 1, pp. 1-6
Open Access
Haylee R. Hammond, Shainnel O. Eans, Thomas J. Cirino, et al.
NeuroImmune Pharmacology and Therapeutics (2023) Vol. 3, Iss. 1, pp. 1-6
Open Access
